Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Xiang-Mei Yao"'
Publikováno v:
Journal of Cellular and Molecular Medicine
Cytoplasmic lncRNAs have been found to directly interact with target mRNAs and regulate their stability. In this study, we aimed to study the molecular mechanism underlying the function of m6A as a central regulator in chemoresistance and CML prolife
Autor:
Ming Jing Fang, Xiang Mei Yao, Hui Yang, Xue Yuan Bo, Li Qun Yu, Bo Nie, Ling Wang, Xun Lai, Xue Zhong Gu, Lung Ji Chang, Yun Yan Sun, Ya Xian Jiang, Yu Ru Ma, Xue Mei Zhang, Yan Wen
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 11, Iss 1, Pp 824-828 (2020)
article-version (VoR) Version of Record
Bioengineered, Vol 11, Iss 1, Pp 824-828 (2020)
CAR-T cells therapy can give rise to most common and concerning two side effects – cytokine release syndrome (CRS) and neurotoxicity. But in our CD19 CAR-T cells therapy clinical trial, we observed 1 out of 17 patients with B-cell acute lymphoblast
Autor:
Yaxian Jiang, Lung-Ji Chang, Xiao-Li Gao, Zi-Jin Dian, Lujia Dong, Xiang-Mei Yao, Xuezhong Gu, Hong-Mei Ou-Yang, Xun Lai, Ya-Yun Wu, Jian-Qiong Liu, Jian-Xin Song
Publikováno v:
Blood. 128:1633-1633
Background: CD19-targeted chimeric antigen receptor (CAR) T cell treatment has emerged as a highly effective therapy in patients with refractory B cell acute lymphoblastic leukemia (B-ALL). Despite obvious successes, there have been documented relaps